Surgery News and Research

RSS

Active ingredient of ipecac syrup inhibits growth of cancer cells

An old home remedy called ipecac syrup, once stocked in medicine cabinets in case of accidental poisoning, is showing promise as a new chemotherapy drug for bladder cancer.

4 Oct 2013

PET/CT imaging provides valuable insight to predict risk of rupture abdominal aortic aneurysms

Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.

4 Oct 2013

Penn Medicine receives $12M NIHM grant for genetics study that points causes of mental illness

A major international consortium co-led by Penn Medicine has received a $12 million National Institute of Mental Health (NIHM) grant for a large-scale genetics study investigating why patients with chromosome 22q11.2 deletion syndrome have an increased risk of schizophrenia and other psychiatric disorders.

4 Oct 2013

UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

Surgeons at UC San Diego Health System have performed the region's first robotic gastrectomy, a potentially lifesaving procedure to remove a section of the stomach after a diagnosis of gastric cancer. Aided by a da Vinci robot, surgeons remove the diseased tissue, perform a delicate reconstruction and remove local lymph nodes for further testing.

3 Oct 2013

Study suggests that surgery may be effective treatment for epilepsy in older patients

A recently published study by researchers from Spectrum Health and Henry Ford Hospital suggests that surgery may be an effective treatment for epilepsy in older patients, a finding that runs counter to conventional treatment methods.

3 Oct 2013

Saint Luke's liver transplantation program receives CMS certification

The liver transplantation program at Saint Luke's Hospital of Kansas City has received certification by the Centers for Medicare and Medicaid. The certification is an important step in enhancing the hospital's ability to care for Medicare-covered patients suffering from end-stage liver disease, and attract other insurers who base their coverage on the CMS certification.

2 Oct 2013

Klox Biophotonic System gets approval in Canada for treatment of acne vulgaris

KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada

2 Oct 2013

Over-the-counter ibuprofen appears to be safest alternative for reducing post-operative pain

You may be able to eat all of the ice cream you want after having your tonsils removed, but researchers at Henry Ford Hospital in Detroit say you don't necessarily need a prescription to reduce post-operative pain -- an over-the-counter pain-reliever is just as effective.

2 Oct 2013

Remote stroke service increases rate of tPA therapy at community hospitals

A telestroke service increases the rate of effective tissue plasminogen activator therapy for patients with acute ischemic stroke treated at community hospitals, according to a report in the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

2 Oct 2013

High blood glucose levels associated with higher risk of wound-related complications

A new study released today shows that among patients undergoing surgery for chronic wounds related to diabetes, the risk of wound-related complications is affected by how well the patient's blood sugar levels are controlled before surgery. These findings appear in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

2 Oct 2013

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.

2 Oct 2013

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute, has identified genes associated with unhealthy liver function.

2 Oct 2013

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.

2 Oct 2013

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Overactive bladder symptom complex is a symptom complex, the pivotal symptom of which is urgency, which is a compelling desire to pass urine, which is difficult to defer.

1 Oct 2013

Scientists move closer to growing therapeutic brain cells in laboratory

Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.

1 Oct 2013

MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has entered into a distribution agreement with Medtronic, Inc. and SpinalGraft Technologies, LLC, a wholly-owned subsidiary of Medtronic.

From Medtronic 1 Oct 2013

University of Sydney to host series of medicine lectures on back pain

On any given day in Australia, one quarter of the population is suffering back pain, and nearly 80 per cent of adult Australians will experience back pain some time during their lives.

1 Oct 2013

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.

1 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Preoperative statin therapy improves results for isolated CABG and AVR operations

Patients receiving statin therapy before coronary artery bypass grafting (CABG) surgery appear to have a reduced risk of post-surgical mortality, stroke, and atrial fibrillation (irregular or rapid heart rate), according to an article in the October 2013 issue of The Annals of Thoracic Surgery.

1 Oct 2013

Surgery News and Research

Active ingredient of ipecac syrup inhibits growth of cancer cells

PET/CT imaging provides valuable insight to predict risk of rupture abdominal aortic aneurysms

Penn Medicine receives $12M NIHM grant for genetics study that points causes of mental illness

UCSD surgeons perform first robotic gastrectomy for gastric cancer treatment

Study suggests that surgery may be effective treatment for epilepsy in older patients

Saint Luke's liver transplantation program receives CMS certification

Klox Biophotonic System gets approval in Canada for treatment of acne vulgaris

Over-the-counter ibuprofen appears to be safest alternative for reducing post-operative pain

Remote stroke service increases rate of tPA therapy at community hospitals

High blood glucose levels associated with higher risk of wound-related complications

FDA grants accelerated approval of Perjeta for people with HER2-positive early stage breast cancer

Genetic study helps identify obese diabetes patients who are at risk of developing NAFLD

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Overactive bladder treatments: an interview with Professor Chris Chapple, Consultant Urological Surgeon at the Royal Hallamshire Hospital and Sheffield Teaching Hospitals NHS Foundation Trust

Scientists move closer to growing therapeutic brain cells in laboratory

MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies

University of Sydney to host series of medicine lectures on back pain

FDA grants accelerated approval to Perjeta for neoadjuvant treatment of breast cancer

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Preoperative statin therapy improves results for isolated CABG and AVR operations

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News